Since the beginning of the HIV epidemic, scientists, doctors, and public health experts have spent decades trying to understand the virus and control its spread. Modern treatments now allow people ...

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning. In the study, run by Excision BioTherapeutics, ...

New research presented early ahead of this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) from a team of researchers in the Netherlands ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

Add Yahoo as a preferred source to see more of our stories on Google. EBT-101 uses AAV9 — a viral delivery vehicle — to carry CRISPR-Cas9 molecular scissors into cells harboring dormant HIV proviral ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

A proof-of-principle study published in Nature Materials shows that gold nanoparticles loaded with CRISPR and other gene-editing tools safely and effectively edited blood stem cells. (Photos, diagram ...

A new, easy-to-use HIV-detection test kit being developed at the University of Florida using advanced CRISPR technology shows promise as an early-warning alarm system that could save millions of lives ...

The 27-year-old patient’s prospects were bleak. In May 2016, he found out he had AIDS. Two weeks later, he was told he had acute lymphoblastic leukemia. But doctors offered the Chinese citizen a ray ...

Trial in six patients found no serious side effects but failed to suppress viral rebound after ART was stopped in four of four cases Al is a long time tech writer with a penchant for all things nerdy.